Literature DB >> 31727725

Association of Imaging-Based Body Fat Distribution and Mammographic Density in the Multiethnic Cohort Adiposity Phenotype Study.

Gertraud Maskarinec1, Michelle Ciba2, Dan Ju3, John A Shepherd2, Thomas Ernst4, Anna H Wu5, Kristine R Monroe5, Unhee Lim2, Lynne R Wilkens2, Loïc Le Marchand2.   

Abstract

BACKGROUND: As the stronger association of obesity with postmenopausal breast cancer in Asian than white women may be due to body fat distribution, we examined the relation of adiposity measures with percent mammographic density (PMD), a strong predictor of breast cancer incidence.
METHODS: A total of 938 women from five ethnic groups (69.1 ± 2.7 years) in the Adiposity Phenotype Study (APS) underwent DXA and MRI imaging. PMD was assessed in routine mammograms using a computer-assisted method. Spearman correlation coefficients were computed and general linear models were applied to estimate regression coefficients (β) for PMD per 0.5 SD units of adiposity measures while adjusting for known confounders, including DXA total body fat.
RESULTS: For 701 (75%) of the participants (69.1 ± 2.7 years), valid mammograms were obtained. Whereas total body fat, the trunk-to-periphery fat ratio (TPFR), visceral fat (VAT), and subcutaneous fat (SAT) were inversely correlated with PMD (P < 0.0001), the VAT/SAT ratio correlated positively (r spearman = 0.10; P = 0.01). In fully adjusted models, PMD remained inversely related to TPFR and SAT and disappeared for VAT, while it was strengthened for VAT/SAT (β = 0.51; P = 0.009). This relation was stronger in Japanese Americans than other ethnic groups.
CONCLUSIONS: This is the first study to show an association of a high VAT/SAT ratio with greater PMD, a marker of breast cancer risk after taking into account total body fat. IMPACT: The results indicate a link between the propensity to accumulate VAT and the amount of fat in the breast (1-PMD), which may influence the relation of obesity with breast cancer incidence. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2019        PMID: 31727725      PMCID: PMC7007361          DOI: 10.1158/1055-9965.EPI-19-1060

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  41 in total

Review 1.  Racial and ethnic disparities in the impact of obesity on breast cancer risk and survival: a global perspective.

Authors:  Elisa V Bandera; Gertraud Maskarinec; Isabelle Romieu; Esther M John
Journal:  Adv Nutr       Date:  2015-11-13       Impact factor: 8.701

2.  Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women.

Authors:  M Gambacciani; M Ciaponi; B Cappagli; L Piaggesi; L De Simone; R Orlandi; A R Genazzani
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

3.  Adverse effects of increased body weight on quantitative measures of mammographic image quality.

Authors:  A R Guest; M A Helvie; H P Chan; L M Hadjiiski; J E Bailey; M A Roubidoux
Journal:  AJR Am J Roentgenol       Date:  2000-09       Impact factor: 3.959

4.  Visceral adiposity increases the risk of breast cancer: a case-control study.

Authors:  Jordana Carolina Marques Godinho-Mota; Karine Anusca Martins; Larissa Vaz-Gonçalves; João Felipe Mota; Leonardo Ribeiro Soares; Ruffo Freitas-Junior
Journal:  Nutr Hosp       Date:  2018-06-10       Impact factor: 1.057

5.  Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites.

Authors:  Malcolm C Pike; Laurence N Kolonel; Brian E Henderson; Lynne R Wilkens; Jean H Hankin; Heather Spencer Feigelson; Peggy C Wan; Daniel O Stram; Abraham M Y Nomura
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-09       Impact factor: 4.254

6.  Does mammographic density reflect ethnic differences in breast cancer incidence rates?

Authors:  Zhengjia Chen; Anna H Wu; W James Gauderman; Leslie Bernstein; Huiyan Ma; Malcolm C Pike; Giske Ursin
Journal:  Am J Epidemiol       Date:  2004-01-15       Impact factor: 4.897

7.  Estrogen Metabolism in Abdominal Subcutaneous and Visceral Adipose Tissue in Postmenopausal Women.

Authors:  Natalia Hetemäki; Hanna Savolainen-Peltonen; Matti J Tikkanen; Feng Wang; Hanna Paatela; Esa Hämäläinen; Ursula Turpeinen; Mikko Haanpää; Veera Vihma; Tomi S Mikkola
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

8.  Height, adiposity and body fat distribution and breast density in young women.

Authors:  Joanne F Dorgan; Catherine Klifa; John A Shepherd; Brian L Egleston; Peter O Kwiterovich; John H Himes; Kelley Gabriel; Linda Horn; Linda G Snetselaar; Victor J Stevens; Bruce A Barton; Alan M Robson; Norman L Lasser; Snehal Deshmukh; Nola M Hylton
Journal:  Breast Cancer Res       Date:  2012-07-13       Impact factor: 6.466

9.  Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan.

Authors:  H Shimizu; R K Ross; L Bernstein; M C Pike; B E Henderson
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

10.  Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.

Authors:  Betsy A Kohler; Recinda L Sherman; Nadia Howlader; Ahmedin Jemal; A Blythe Ryerson; Kevin A Henry; Francis P Boscoe; Kathleen A Cronin; Andrew Lake; Anne-Michelle Noone; S Jane Henley; Christie R Eheman; Robert N Anderson; Lynne Penberthy
Journal:  J Natl Cancer Inst       Date:  2015-03-30       Impact factor: 13.506

View more
  3 in total

1.  Body Mass Index and Mammographic Density in a Multiracial and Multiethnic Population-Based Study.

Authors:  Karen Curtin; Jennifer Anne Doherty; Mollie E Barnard; Tarun Martheswaran; Margaret Van Meter; Saundra S Buys
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-07-01       Impact factor: 4.090

2.  Noninvasive, longitudinal imaging-based analysis of body adipose tissue and water composition in a melanoma mouse model and in immune checkpoint inhibitor-treated metastatic melanoma patients.

Authors:  Wolfgang M Thaiss; Sergios Gatidis; Tina Sartorius; Jürgen Machann; Andreas Peter; Thomas K Eigentler; Konstantin Nikolaou; Bernd J Pichler; Manfred Kneilling
Journal:  Cancer Immunol Immunother       Date:  2020-11-01       Impact factor: 6.968

3.  Body fatness and breast cancer risk in relation to phosphorylated mTOR expression in a sample of predominately Black women.

Authors:  Ting-Yuan David Cheng; Angela R Omilian; Song Yao; Weizhou Zhang; Susmita Datta; Wiam Bshara; Rochelle Payne Ondracek; Warren Davis; Song Liu; Chi-Chen Hong; Elisa V Bandera; Thaer Khoury; Christine B Ambrosone
Journal:  Breast Cancer Res       Date:  2021-07-30       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.